by Bill Malloy | Mar 21, 2025 | Scientists, Technology
Immunis.AI is a promising immunogenomics company that is using cutting-edge technology to revolutionize disease management. Through innovative technologies and groundbreaking research, Immunis.AI leverages the body’s immune defense system to provide unparalleled...
by Bill Malloy | Oct 8, 2024 | Cancer, Health, Scientists, Technology
In an era where artificial intelligence (AI) is advancing at a remarkable rate, a recent study indicates that it has the potential to identify more cases of breast cancer than seasoned medical professionals. The research also revealed that integrating AI technology...
by Bill Malloy | Feb 5, 2024 | Cancer, Scientists
A recent study out of the University of Texas Southwestern Simmons Cancer Center showed that lactate—a metabolic byproduct produced during exercise—could be used to enhance cancer immunotherapy. The researchers believe that lactate could be used to rejuvenate...
by Bill Malloy | Jun 21, 2023 | Cancer, Scientists
In a recent study by the University of Texas Division of Cancer Medicine, researchers found that a drug commonly used to treat bile duct cancer could also be useful as a treatment for patients with upper tract urothelial cancer (UTUC). Infigratinib (brand name...
by Bill Malloy | May 16, 2022 | Health, Medication, Scientists
Colorectal cancer is one of the most common forms of cancer and, as the second-leading cause of cancer deaths, it is also one of the most serious. For years, cancer researchers have been searching for ways to prevent and treat colorectal cancer more...
by Bill Malloy | May 9, 2022 | Health, Pharmaceuticals, Scientists, Uncategorized
A potential cancer immunotherapy treatment has been developed by researchers at Purdue University’s College of Pharmacy. Led by Zhong-Yin Zhang, the researchers are continuing to develop the immunotherapy treatment, which is based on an enzyme mutation. The team of...
